Gary Wu, MD, University of Pennsylvania
“Bidirectional interactions between the small intestinal microbiota and bile acids in health and disease”
“Bidirectional interactions between the small intestinal microbiota and bile acids in health and disease”
"Fecal Microbial Transplant for Inflammatory Bowel Disease - Microbiome-based Mechanisms of Patient Response."
"Alcoholic hepatitis: Clinical management and identification of novel therapeutic targets by multi-omics."
“Finding New Targets For Alcoholic Hepatitis”
"Fusobacterium nucleatum in intestinal inflammation and preneoplasia"
"The gut microbiome as regulator of immunity and outcomes in liver transplantation"
"Long-coding RNAs in Celiac Disease Pathophysiology"
"Introducing the DLDRC Bioinformatics Core." & "The DLDRC Clinical Biospecimen and Research Core (CBRC)."
"The many tiers of liver repair: Prometheus needed them all"
Hepatic Fibrosis – Big Questions and New Paradigms. This lecture will focus on emerging advances and opportunities for understanding and treating hepatic fibrosis. The lecture is framed around five “big questions”: 1) What determines whether there is healing with regeneration or fibrotic progression? 2) What are the implications of fibroblast heterogeneity? 3) What regulates […]